OxVax

OxVax Ltd. is a spin-out company from the University of Oxford that is focused on developing an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers. Their main goal is to revolutionize cancer treatment by harnessing the power of dendritic cells to stimulate the immune system and target cancer cells specifically. Their achievements include being selecte...